Forum

Events

Partner Content

Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.

News

Pfizer's JAK inhibitor Litfulo hits the mark in vitiligo, setting up filings, as Incyte claims EU approval for Opzelura in atopic dermatitis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.